Gender Differences in Acute Stroke Treatment
Open Access
- 1 August 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 41 (8), 1755-1757
- https://doi.org/10.1161/STROKEAHA.110.584136
Abstract
Background and Purpose— To assess the gender differences in patients with acute ischemic stroke treated with and without tissue plasminogen activator. The primary purpose is to evaluate for differences in baseline risk factors, treatment times, and 90-day outcomes. Data regarding gender differences in acute stroke treatment shows a delayed treatment and evaluation in women with stroke, associated with poorer outcome. Methods— Review of the University of California San Diego Specialized Program for Translational Research in Acute Stroke (SPOTRIAS) database from 2001 to 2009. All “code stroke” patients with the admitting diagnosis of acute ischemic stroke were classified based on gender and tissue plasminogen activator treatment (group 1 with tissue plasminogen activator, group 2 without). Results— A total of 848 patients were included, group 1: 294 patients, baseline median NIHSS and mean age in men was 10 and 67.6±16.5 years, in women 13 and 72.4±16.5 years. group 2: 554 patients, baseline median NIHSS and mean age in men was 4 and 68.4±14.0 years, in women 5 and 72.2±14.0 years. Women and men had a similar tissue plasminogen activator treatment rate (women=38%, men=32%). Men were more likely to use tobacco and have a history of coronary artery disease and less likely to have a history of atrial fibrillation. In both groups, men had higher rates of a 90-day modified Rankin scale score of 0 to 1 compared to women (group 1 35.5% vs 22.6%; group 2 57.3% vs 47.3%). Multivariable analysis adjusting for observed confounders, namely admission NIHSS, coronary artery disease/myocardial infarction, and atrial fibrillation, indicate that this difference was not statistically significant. We found no significant difference between genders when assessing for treatment times in either group. Conclusions— Treatment times and patient outcomes after treatment for acute ischemic stroke were similar between genders. Previously identified gender differences in stroke treatment times and outcome were not found in our sample.Keywords
This publication has 15 references indexed in Scilit:
- Gender Differences in Management and Outcome of Acute Myocardial Infarctions Treated in 2006–2007JMIR AI, 2009
- Sex Differences in Acute Stroke Care in a Statewide Stroke RegistryStroke, 2008
- Sex Disparity in the Access of Elderly Patients to Acute Stroke CareStroke, 2007
- Prehospital and hospital delays after stroke onset--United States, 2005-2006.2007
- Intravenous alteplase for ischaemic strokeThe Lancet, 2007
- Barriers to intravenous tissue plasminogen activator for acute stroke therapy in womenGender Medicine, 2006
- IV tissue plasminogen activator use in acute strokeNeurology, 2006
- Influence of Gender on Baseline Features and Clinical Outcomes among 17,370 Patients with Confirmed Ischaemic Stroke in the International Stroke TrialNeuroepidemiology, 2005
- Recommendations for the Establishment of Primary Stroke CentersJAMA, 2000
- Duration of, and Temporal Trends (1994-1997) in, Prehospital Delay in Patients With Acute Myocardial InfarctionArchives of Internal Medicine, 1999